COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR
- 专利权人:
- CHEMOCENTRYX; INC.
- 发明人:
- James J. CAMPBELL,Zhenhua MIAO
- 申请号：
- US16358311
- 公开号：
- US20190275015A1
- 申请日:
- 2019.03.19
- 申请国别(地区):
- US
- 年份:
- 2019
- 代理人:
- 摘要：
- The present disclosure is drawn to the combination therapy of a Chemokine Receptor 2 (CCR2) antagonist and a PD-1 and/or PD-L1 inhibitor in the treatment of cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- טיפול בשילוב של מעכבי קולטן כימוקין 2 (ccr2) ומעכב pd-1/pd-l1
- COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR
- Combination therapy using a Chemokine Receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor
- Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a PD-1 and/or PD-L1 Inhibitor
- COMBINATION THERAPY USING C-C CHEMOKINE RECEPTOR 4 (CCR4) ANTAGONISTS AND ONE OR MORE IMMUNE CHECKPOINT INHIBITORS
